Pēdējā atjaunošana :
29/10/2024
Infostab
Saraksti
Kopsavilkums
Meklēt saderības
Y-savienojuma saderības tabula
Literatūras saraksts
pētniecības grupas
valistab
plakāts
Savienojumi
sponsori
Autori
Lietošanas instrukcija
Newsletter
Etoposide phosphate
Ķīmiskā uzbūve
Oriģinālais nosaukums
Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām
Etopofos
Argentīna, Austrija, Dānija, Norvēģija, Somija, Zviedrija
Etopophos
Amerikas Savienotās Valstis, Beļģija, Bulgārija, Dienvidāfrikas Republika, Francija, Holande, Izraēla, Jaunzēlande, Lielbritānija, Luksemburga, Polija, Šveice, Vācija
Nexvep
Brazīlija
Toposar
Amerikas Savienotās Valstis
Literatūras saraksts : Etoposide phosphate
tips
publicēšana
1410
Žurnāls
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1411
Žurnāls
Zhang Y, Trissel LA.
Physical and chemical stability of etoposide phosphate solutions.
J Am Pharm Assoc 1999 ; 39: 146-150.
1423
Žurnāls
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1606
Žurnāls
Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK.
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 2001 ; 58: 594-598.
1625
Žurnāls
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1662
Žurnāls
Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1925
Žurnāls
Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1982
Žurnāls
Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2247
Žurnāls
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262
Žurnāls
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3644
Laboratorija
Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3655
Laboratorija
Etoposide phosphate (Etopophos®) - Résumé des caractéristiques du produit
Bristol Myers Squibb 2016
3838
Laboratorija
Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007
4102
Žurnāls
Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y.
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.
J Oncol Pharm Practice 2018 ;25,4:831-840.
Mentions Légales